References
-
1
Forst Th, Kunt Th, Pohlmann Th, Goitom K, Engelbach M, Beyer J, Pfuetzner A.
Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus.
J Clin Invest.
1998;
101
2036-2041
-
2
Linn T, Ortac K, Laube H, Federlin K.
Intensive therapy in adult insulin-dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: a randomised, controlled prospective study over 5 years in newly diagnosed patients.
Metabolism.
1996;
45
1508-1513
-
3
Muehlhauser I, Overmann H, Bender R, Bott U, Berger M.
Risk factors of severe hypoglycemia in adult patients with type 1 diabetes - a prospective population based study.
Diabetologia.
1998;
41
1274-1282
-
4
Muller U A, Femerling M, Reinauer K M, Risse A, Voss M, Jorgens V, Berger M, Muhlhauser I.
Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association).
Diabetes Care.
1999;
22 (Suppl 2)
B29-34
-
5
Schiffrin A, Suissa S, Weitzner G. et al .
Factors predicting course of B-cell function in IDDM.
Diabetes Care.
1992;
15
997-1001
-
6
The Diabetes Control and Complications Trial Study Group .
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
N Engl J Med.
1993;
329
977-989
-
7
The Diabetes Control and Complications Trial Study Group .
Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial.
Ann Intern Med.
1998;
128
517-523
-
8
Torgerson D J, Sibbald B.
What is a patient preference trial?.
Brit Med J.
1998;
316
360
Prof. Dr. med. Thomas Linn
Clinical Research Unit, 3rd Medical Clinic and Policlinic, Justus Liebig University
Rodthohl 6
35385 Gießen
Germany
Telefon: + 496419942841
Fax: + 49 64 19 94 28 49
eMail: thomas.linn@innere.med.uni-giessen.de
